179 related articles for article (PubMed ID: 21953546)
1. Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.
Shah T; Stasinopoulos I; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2012 May; 25(5):746-54. PubMed ID: 21953546
[TBL] [Abstract][Full Text] [Related]
2. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
3. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
4. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.
Shah T; Wildes F; Penet MF; Winnard PT; Glunde K; Artemov D; Ackerstaff E; Gimi B; Kakkad S; Raman V; Bhujwalla ZM
NMR Biomed; 2010 Jul; 23(6):633-42. PubMed ID: 20623626
[TBL] [Abstract][Full Text] [Related]
5. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.
Natarajan K; Mori N; Artemov D; Bhujwalla ZM
Neoplasia; 2002; 4(5):409-16. PubMed ID: 12192599
[TBL] [Abstract][Full Text] [Related]
6. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
8. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
9. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
12. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
13. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype.
Vesuna F; Penet MF; Mori N; Bhujwalla ZM; Raman V
Mol Cell Biochem; 2023 Apr; 478(4):939-948. PubMed ID: 36136285
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.
Ackerstaff E; Gimi B; Artemov D; Bhujwalla ZM
Neoplasia; 2007 Mar; 9(3):222-35. PubMed ID: 17401462
[TBL] [Abstract][Full Text] [Related]
15. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
[TBL] [Abstract][Full Text] [Related]
16. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
[TBL] [Abstract][Full Text] [Related]
18. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
19. Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.
Su JS; Woods SM; Ronen SM
NMR Biomed; 2012 Feb; 25(2):379-88. PubMed ID: 22253088
[TBL] [Abstract][Full Text] [Related]
20. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells.
Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM
Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]